Treating Prostate Cancer in Men with Low Prostate-Specific Antigen Levels; Most men had low-risk disease but received aggressive therapy
Most prostate cancer is now detected at a localised stage, presumably because of screening for prostate-specific antigen (PSA), and the 5-year survival rate for patients with local disease is nearly 100%. Some experts are now concerned about over-diagnosis and overly aggressive treatment, yet others argue for lowering the PSA threshold for biopsy even further.
read more